Cargando…
UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
BACKGROUND: To discover biomarker panels that could distinguish cancers (BC and RCC) from healthy controls (HCs) and bladder cancers (BC) from renal cell carcinoma (RCC), regardless of whether the patients have haematuria. In addition, we also explored the altered metabolomic pathways of BC and RCC....
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896793/ https://www.ncbi.nlm.nih.gov/pubmed/31805976 http://dx.doi.org/10.1186/s12885-019-6354-1 |